Eliana L. Ruggiero
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
N-glycans in non-malignant tumor microenvironment cells dampen CAR-T cell function in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 29, 2026
Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.
Journal: Clinical lung cancer
Published: January 11, 2026
Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial.
Journal: BMC cancer
Published: October 27, 2025
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Journal: Nature immunology
Published: September 17, 2024
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
Journal: Frontiers in immunology
Published: February 02, 2024
Epigenetic checkpoints regulate the fate and function of CAR-T cells.
Journal: Nature immunology
Published: January 03, 2024
In Vitro Evaluation of Cancer Cell Immunogenicity and Antigen-Specific T-Cell Cytotoxicity by Flow Cytometry.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 09, 2023
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors.
Journal: Seminars in immunopathology
Published: December 04, 2023
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Journal: Science advances
Published: December 01, 2023
Last Updated: 09/26/2026